http://pediatrics.aappublications.org/cgi/content/abstract/112/1/e6

Full Text of this Article Reprint (PDF) Version of this Article Email this article to a friend P3Rs: Submit a response to this article Similar articles found in: Pediatrics Online PubMed PubMed Citation Search PubMed for articles by: Iwamoto, M. || Pickering, L. K. Alert me when: new articles cite this article   Download to Citation Manager

Collections under which this article appears: Infectious Disease & Immunity

Related AAP Red Book topics:     Rotavirus Infections

PEDIATRICS Vol. 112 No. 1 July 2003, pp. e6-e10

 

A Survey of Pediatricians on the Reintroduction of a Rotavirus Vaccine

Martha Iwamoto, MD, MPH^*, Thomas N. Saari, MD, Shawn R. McMahon, MD, MPH, Hussain R. Yusuf, MBBS, MPH, Mehran S. Massoudi, PhD, MPH, John M. Stevenson, MA, Susan Y. Chu, PhD, MSPH and Larry K. Pickering, MD

^* Rollins School of Public Health, Emory University, Atlanta, Georgia
University of Wisconsin Children’s Hospital, Madison, Wisconsin
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia

Objective. Rhesus-based rotavirus tetravalent vaccine (RRV-TV; RotaShield) was withdrawn voluntarily from the market in October 1999, and recommendations for use were suspended. Rotavirus infection continues to be a significant health problem affecting children worldwide. The objective of this study was to investigate whether pediatricians would either reconsider using RRV-TV or consider other, newer, and presumably safer rotavirus vaccines if they were recommended routinely and to determine factors that influence their opinion.

Methods. A questionnaire was sent to a random sample of 250 members of the Wisconsin Chapter of the American Academy of Pediatrics (AAP) and to 437 randomly selected members of the Georgia Chapter of the AAP. Nonresponders received reminder questionnaires.

Results. Of the 687 pediatricians surveyed, 384 (56%) responded. Responses from 319 eligible immunization providers were included in the final analysis. Although only 15% of respondents reported that they would give RRV-TV if it were available today, 94% reported that they would use a new rotavirus vaccine if proved to be safer than RRV-TV and if recommended by the AAP and Advisory Committee on Immunization Practices for routine use among infants. Barriers to reintroducing a rotavirus vaccine were fear of adverse reactions among 95% of pediatricians, followed by potential high vaccine cost (63%) and amount of time required to educate parents (57%).

Conclusions. Pediatricians reported that they would use a rotavirus vaccine if it was safer than RRV-TV and routinely recommended by the AAP and the Advisory Committee on Immunization Practices.

Key Words: rotavirus • rotavirus vaccine • RRV-TV

Abbreviations: RRV-TV, rhesus-based rotavirus tetravalent vaccine • AAP, American Academy of Pediatrics • ACIP, Advisory Committee on Immunization Practices

Received for publication Jun 13, 2002; accepted Mar 13, 2003.

Copyright © 2003 by the American Academy of Pediatrics. [Disclaimer]